Medicinal Chemistry
Division Head
Whitman's laboratory is interested in how enzymes evolve and how they work. They are studying two groups of enzymes, the tautomerase superfamily and the fumaryl acetoacetate hydrolase (FAH) superfamily.
Faculty
Dalby's laboratory endeavors to identify
potential for cancer treatment through the targeting of protein kinases by utilizing novel efforts in chemical biology.
Davis' current research efforts are focused in two areas: (1) the impact of educational technology on teaching and learning in the scientific component of the professional (PharmD) curriculum; and (2) the use of computer modeling and computational chemistry in predicting drug metabolism.
Fast's Lab is interested in merging chemical biology with more classical biochemical and enzymological approaches in the investigation
and manipulation of two enzyme superfamilies of therapeutic interest, the pentein superfamily and the metallo-beta-lactamase
superfamily.
Kerwin's research combines synthetic organic chemistry with computational, biochemical, and molecular biological tools in an interdisciplinary approach to designing drugs that specifically target diseased cells or infectious agents. The long-term goal is the development of selective strategies for the treatment of cancer and infectious diseases.
Lee's lab researches damage, repair, and enzymatic
modifications of DNA and RNA and is striving to discover potent chemotherapeutics that
selectively inhibit DNA-modifying enzymes.
Liu's research lies at the crossroads of chemistry and biology. His group is currently working on three general areas with the focus aimed at the elucidation of the mechanisms of novel enzymatic reactions and the design of methods to control and/or regulate their functions.
Link to our
directories page for additional directory information.
Last Reviewed: January 9, 2012
